335
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Applicability of two automated disintegration apparatuses for rapidly disintegrating (mini)tablets

, , &
Pages 198-205 | Received 02 Dec 2015, Accepted 24 Mar 2016, Published online: 07 Jun 2016

References

  • Stoltenberg I, Breitkreutz J. Orally disintegrating mini-tablets (ODMTs) – a novel solid oral dosage form for paediatric use. Eur J Pharm Biopharm 2011;78:462–469.
  • Klingmann V, Spomer N, Lerch C. Favorable acceptance of mini-tablets compared with syrup: a randomized controlled trial in infants and preschool children. J Pediatr 2013;163:1728–1732.
  • Lennartz P, Mielck JB. Minitabletting: Improving the compactability of paracetamol powder mixtures. Int J Pharm 1998;173:75–85.
  • European Pharmacopoeia, 8th ed. (8.4), Strasbourg Cedex, France; 2014:285–287.
  • Preis M. Orally disintegrating films and mini-tablets – innovative dosage forms of choice for pediatric use. AAPS PharmSciTech 2015;16:8 p.
  • Slavkova M, Breitkreutz J. Orodispersible drug formulations for children and elderly. Eur J Pharm Sci 2015; 75:2–9.
  • Park JH, Holman KM, Bish GA. An alternative to the USP disintegration test for orally disintegrating tablets. Pharm Technol 2008; 32:54–58.
  • Kakutani R, Muro H, Makino T. Development of a new disintegration method for orally disintegrating tablets. Chem Pharm Bull 2010;58:885–890.
  • Dor PJM, Fix JA. In vitro determination of disintegration time of quick-dissolve tablets using a new method. Pharm Dev Technol 2000;5:575–577.
  • Abdelbary G, Eonani C, Prinderre P. Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration. Int J Pharm 2005;292:29–41.
  • Szakonyi G, Zelkó R. Prediction of oral disintegration time of fast disintegrating tablets using texture analyzer and computational optimization. Int J Pharm 2013;448:346–353.
  • Narazaki R, Harrada T, Takami N. A new method for disintegration studies of rapid disintegrating tablet. Chem Pharm Bull 2004;52:704–707.
  • Harada T, Narazaki R, Nagira S. Evaluation of the disintegration properties of commercial famotidine 20 mg orally disintegrating tablets using a simple new test and human sensory test. Chem Pharm Bull 2006;54:1072–1075.
  • Harada T, Uchida T, Yoshida T. A new method for evaluating the bitterness of medicines in development using a taste sensor and a disintegration testing apparatus. Chem Pharm Bull 2010;58:1009–1014.
  • Brniak W, Jachowicz R, Krupa A. Evaluation of co-processed excipients used for direct compression of orally disintegrating tablets (ODT) using novel disintegration apparatus. Pharm Dev Technol 2013;18:464–474.
  • Hermes M. Kindgerechte, niedrigdosierte Zubereitungen mit Enalaprilmaleat (Dissertation); 2012. Cuvillier, Göttingen: Cuvillier.
  • International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), Q2 (R1): Validation of Analytical Procedures: Text and Methodology; 2005.
  • Kleinebudde P. Christian-Albrechts-Universität zu Kiel. habilitation thesis. Kiel; 1997.
  • Potter NL, Short R. Maximal tongue strength in typically developing children and adolescents. Dysphagia 2009; 24:391–397.
  • Huber L, Wiederoder H. Qualification and validation of software and computer systems in laboratories. Part 1: Validation during development. Valid Chem Meas 2005;1:24–30.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.